Evan Leitner

Associate


eleitner@cooley.com

Evan Leitner is an associate in Cooley's business practice department and focuses on general corporate law.

Download full bio

Experience

  • Morphic Therapeutics - $104 Million IPO 

  • Akero Therapeutics - $106 Million IPO 

  • Bicycle Therapeutics - $61 Million IPO 

Education

  • New York University School of Law
    JD, 2015

  • Yale University
    BA, 2009


Admissions & Credentials

New York

New Jersey

Not admitted to practice in Massachusetts